Trial Profile
A Trial of the Safety and Efficacy of K-604 for the Treatment of Atherosclerosis.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs K 604 (Primary)
- Indications Atherosclerosis
- Focus Therapeutic Use
- 16 Aug 2011 Actual end date (Aug 2011) added as reported by ClinicalTrials.gov.
- 16 Aug 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 07 Jun 2011 Planned End Date changed from 1 Apr 2010 to 1 Dec 2011 as reported by ClinicalTrials.gov.